Registration Open

Target Audience

The target audience for this conference is women in hematology/oncology careers seeking professional networking and science-based insights into the hematology/oncology landscape.

Learning Objectives

After completing this activity, participants should be better able to:

• Evaluate the role that biomarkers have played in clinical drug development and in treatment selection with certain agents
• Review recent approvals and clinical trial data of cell-based therapies and immunotherapies in lung and cervical cancer and B cell malignancies
• Explore new molecular targets and recently approved small molecule inhibitors in breast, lung, ovarian, and bladder cancer
• Acquire career development techniques and clinical science skills
• Foster and enrich collaboration among women oncologists and bridge the academic-community gap

Registration Rates

Register